GlassScriptPhysician profile
Susan C Lodenquai
NPI 1336146257
$1,651.12
in general payments reported to CMS, 2019-2025
13 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $196 · 2021: $42.93 · 2022: $14.50 · 2023: $57.42 · 2024: $405 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750 · Entertainment: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.61 |
| Entertainment | $112.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $521.90 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $296.99 | 2019-2025 | Acuvue |
| Sight Sciences, INC. | $149.71 | 2024 | Omni Surgical System |
| Alcon Vision LLC | $130.65 | 2021-2025 | Precision7, Dailies |
| Allergan, INC. | $125.00 | 2020 | |
| Rxsight INC | $114.02 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Optos, INC. | $112.98 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Amgen INC. | $97.45 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $31.07 | 2025 | |
| Abb Con-Cise Optical Group LLC | $21.62 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Coopervision INC. | $13.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Lodenquai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.